DRDGOLD Limited, a gold mining company, engages in the surface gold tailings retreatment business in South Africa. The company is involved in the exploration, extraction, processing, and smelting activities. It recovers gold from surface tailings in the Witwatersrand basin in Gauteng province. The company was founded in 1895 and is headquartered in Johannesburg, South Africa.
IPO Year:
Exchange: NYSE
Website: drdgold.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/26/2021 | $18.25 → $18.00 | Buy | HC Wainwright & Co. |
| 8/26/2021 | $19.25 → $18.25 | Buy | HC Wainwright & Co. |
Johannesburg, South Africa--(Newsfile Corp. - November 8, 2022) - DRDGOLD Limited (JSE: DRD) (NYSE:DRD), today announced that Niel Pretorius, Chief Executive Officer of DRDGOLD Limited will be attending the Q4 Investor Summit live in NYC at the Sheraton Times Square. During the presentation, DRDGOLD's Chief Executive Officer, Niel Pretorius, will introduce the Company and its value proposition of gold-price exposure, ESG and dividend history. The presentation will be made available on the DRDGOLD website at www.drdgold.com on 14th November 2022.Event: Q4 Investor SummitDate: November 14-15, 2022Presentation: November 14 at 1:00 P.M. ETLocation: Sheraton New York Times Square Hotel,
New York, Feb. 16, 2021 (GLOBE NEWSWIRE) -- - LiteLink Technologies Inc (CSE:LLT) (OTCMKTS:LLNKD) (FRA:C0B0) to acquire an ownership interest in Canadian cryptocurrency exchange CatalX CTS click here - Cabral Gold Inc (CVE:CBR) (OTCPINK:CBGZF) (FRA:C3J) adds third drill rig to 5,000m program at Cuiú Cuiú project in Brazil click here - American Resources Corporation (NASDAQ:AREC) signs exclusive licenses for rare earth mineral processing and graphene patents from Ohio University click here - Predictmedix Inc (CSE:PMED) (OTCQB:PMEDF) notes recent deployment of its screening technology in Tampa Bay, Florida click here - Great Bear Resources Ltd (CVE:GBR) (OTCQX:GTBAF) (FR
New York, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) (FRA:AGW) poised to investigate psychedelic compound DMT as treatment for stroke click here Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) (FRA:AC4) acquiree ALPS inks deal to build a high-tech California greenhouse click here Empower Clinics' Inc (CSE:CBDT:) (OTCQB:EPWCF) (FRA:8EC) Kai Medical Laboratory to deliver on-site COVID-19 testing for Dallas Market Center click here Imagine AR Inc (CSE:IP) (OTCMKTS:IPNFF) (FRA:GMS1) brings on technology executive Masa Ishimitsu as advisor to help launch augmented reality platform in Japan click here CytoDyn Inc (OTCQB: C
6-K - DRDGOLD LTD (0001023512) (Filer)
SD - DRDGOLD LTD (0001023512) (Filer)
6-K - DRDGOLD LTD (0001023512) (Filer)
6-K - DRDGOLD LTD (0001023512) (Filer)
6-K - DRDGOLD LTD (0001023512) (Filer)
6-K - DRDGOLD LTD (0001023512) (Filer)
6-K - DRDGOLD LTD (0001023512) (Filer)
6-K - DRDGOLD LTD (0001023512) (Filer)
6-K - DRDGOLD LTD (0001023512) (Filer)
20-F - DRDGOLD LTD (0001023512) (Filer)
SC 13D - DRDGOLD LTD (0001023512) (Subject)
SC 13G - DRDGOLD LTD (0001023512) (Subject)
HC Wainwright & Co. reiterated coverage of DRDGold with a rating of Buy and set a new price target of $18.00 from $18.25 previously
HC Wainwright & Co. reiterated coverage of DRDGold with a rating of Buy and set a new price target of $18.25 from $19.25 previously
HC Wainwright & Co. reiterated coverage of DRDGold with a rating of Buy and set a new price target of $19.25 from $19.00 previously
HC Wainwright & Co. reiterated coverage of DRDGold with a rating of Buy and set a new price target of $19.00 from $19.50 previously